Bretylium Tosylate Injection
»Bretylium Tosylate Injection is a sterile solution of Bretylium Tosylate in Water for Injection.It contains not less than 90.0percent and not more than 110.0percent of the labeled amount of C18H24BrNO3S.
Packaging and storage— Preserve in single-dose containers,preferably of Type Iglass.
Identification— The retention time of the major peak in the chromatogram of the Assay preparationcorresponds to that of the Standard preparation,both relative to the internal standard,as obtained in the Assay.
Bacterial endotoxins á85ñ It contains not more than 0.20USP Endotoxin Unit per mg of bretylium tosylate.
pHá791ñ: between 3.5and 7.0.
Particulate matter á788ñ: meets the requirements for small-volume injections.
Other requirements— It meets the requirements under Injections á1ñ.
Assay—
pH3.1Tetramethylammonium phosphate buffer— Dissolve 1.38g of monobasic sodium phosphate and 2.0mLof 25%tetra-methylammonium hydroxide solution in methanol in 800mLof water,adjust with phosphoric acid to a pHof 3.1±0.1,dilute with water to 1000mL,and mix.
Mobile phase— Transfer 15mLof tetrahydrofuran and 75mLof acetonitrile to a 1000-mLvolumetric flask,and dilute with pH3.1Tetramethylammonium phosphate bufferto volume.
Standard preparation— Dissolve an accurately weighed quantity of USP Bretylium Tosylate RSin water,and dilute quantitatively,and stepwise if necessary,with water to obtain a solution having a known concentration of about 0.2mg per mL.
Assay preparation— Transfer an accurately measured volume of Injection,equivalent to about 10mg of bretylium tosylate,to a 50-mLvolumetric flask,dilute with water to volume,and mix.
Chromatographic system (see Chromatography á621ñ)—The liquid chromatograph is equipped with a 220-nm detector and a 3.9-mm ×30-cm column that contains packing L1.The flow rate is about 2mLper minute.Chromatograph the Standard preparation,and record the peak responses as directed for Procedure:the relative retention times are about 0.7for tosylate and 1.0for bretylium;the resolution,R,between the bretylium and tosylate peaks is not less than 3.0;and the relative standard deviation for replicate injections is not more than 1.4%.
Procedure— Separately inject equal volumes (about 20µL)of the Standard preparationand the Assay preparationinto the chromatograph,record the chromatograms,and measure the responses for the major peaks.Calculate the quantity,in mg,of C18H24BrNO3Sin each mLof the Injection taken by the formula:
50(C/V)(rU/rS),
in which Cis the concentration,in mg per mL,of USP Bretylium Tosylate RSin the Standard preparation;Vis the volume,in mL,of Injection taken;and rUand rSare the bretylium peak responses obtained from the Assay preparationand the Standard preparation,respectively.
Auxiliary Information— Staff Liaison:Andrzej Wilk,Ph.D.,Senior Scientific Associate
Expert Committee:(PA5)Pharmaceutical Analysis 5
USP28–NF23Page 280
Phone Number:1-301-816-8305